SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-038095
Filing Date
2023-08-03
Accepted
2023-08-03 16:36:37
Documents
12
Period of Report
2023-08-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K oncr-20230801.htm   iXBRL 8-K 79407
  Complete submission text file 0000950170-23-038095.txt   205297

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20230801.xsd EX-101.SCH 2459
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20230801_pre.xml EX-101.PRE 11430
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20230801_lab.xml EX-101.LAB 13904
6 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20230801_htm.xml XML 4911
Mailing Address 4 CORPORATE DRIVE ANDOVER MA 01810
Business Address 4 CORPORATE DRIVE ANDOVER MA 01810 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39575 | Film No.: 231140714
SIC: 2834 Pharmaceutical Preparations